Connected Drug Delivery Devices Market Trends : to Surpass USD 2.1 Billion by 2030, Claims AMR

Connected drug delivery devices refer to intelligent electronic tools that enable patients to self-administer therapy wirelessly. Utilizing mechanisms like auto-injectors, smart inhalers, and closed-loop solutions, these devices have shown promise in enhancing patient adherence and minimizing dosage errors, especially within a home environment. They find application in treating a range of conditions including multiple sclerosis, diabetes, liver and renal transplant recipients, hepatitis C, hypertension, asthma, tuberculosis, and clinically isolated syndrome.

The connected drug delivery devices market size was $290.30 million in 2021, and is estimated to reach $2.1 billion by 2030, growing at a CAGR of 24.3% from 2022 to 2030.

• CAGR: 24.3%
• Current Market Size: USD 290.3 Million
• Forecast Growing Region: APAC
• Largest Market: North America
• Projection Time: 2022 – 2030
• Base Year: 2022

𝑹𝒆𝒒𝒖𝒆𝒔𝒕 𝑺𝒂𝒎𝒑𝒍𝒆 Copy of Report https://www.alliedmarketresearch.com/request-sample/26467

Connected Drug Delivery Devices Market Segmentation-

By Type	Injectable Inhalation Devices
By Technology	Bluetooth NFC Others
By End-use	Homecare Hospitals
By Region	North America  (U.S., Canada, Mexico) Europe  (Germany, United Kingdom, France, Spain, Italy, Rest of Europe) Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest Of Asia Pacific) LAMEA  (Brazil, Saudi Arabia, UAE, South Africa, Rest of LAMEA)

Impact of COVID-19 on the Global Connected Drug Delivery Devices Market

• The COVID-19 pandemic led to a slight downturn in the sales of connected drug delivery devices for medical device manufacturers. This decline can be attributed to disruptions in global distribution and sales channels. During the pandemic, limitations imposed on individuals resulted in a reduced rate of disease diagnosis and screening. Furthermore, the research and development efforts within the pharmaceutical industry were hindered, impacting market growth.
• Nevertheless, the COVID-19 crisis underscored the necessity for accessible and secure homecare solutions. The demand for online connectivity devices rose, enabling healthcare professionals to remotely monitor a patient’s medication. Consequently, these developments helped alleviate the adverse effects of the pandemic, allowing the market to sustain a steady growth trajectory.

Procure Complete Report (210 Pages PDF with Insights, Charts, Tables, and Figures) @ https://www.alliedmarketresearch.com/connected-drug-delivery-devices-market/purchase-options

Key Findings of the Study

• Based on type, the injectable devices sub-segment emerged as a dominating leader in 2021 and the inhalation devices are anticipated to be the fastest growing sub-segment during the forecast period
• Based on technology, the NFC sub-segment emerged as the fastest growing sub-segment and the Bluetooth sub-segment is predicted to be the dominating in the upcoming years
• Based on end-user, the homecare settings sub-segment emerged as the fastest growing and the hospitals sub-segment is predicated as dominating in the market during the forecast period
• Based on region, the North America market registered the highest market share in 2021 and Asia-Pacific region is anticipated to be the fastest growing in the market during the forecast period.

Connected Drug Delivery Devices Market Regional Analysis

North America:

• • In 2021, North America generated substantial revenue and is forecasted to maintain its dominance in the global connected drug delivery devices market over the projected period. This is primarily attributed to the region’s advanced healthcare infrastructure, significant healthcare expenditure, the presence of key market players, and strategic partnerships. Additionally, the increasing prevalence of chronic diseases in the U.S. and a growing emphasis on preventive healthcare are expected to further fuel market growth in this region.

Asia-Pacific:

• • The Asia-Pacific region is witnessing significant opportunities for market growth due to factors such as growing awareness regarding connected drug delivery devices, cost advantages, and the rapid adoption of medical technology in countries like China and India. These factors contribute to the region’s potential for considerable market expansion.

Rest of the World:

• • In other parts of the world, the connected drug delivery devices market is anticipated to gain traction due to the implementation of robust marketing strategies by market players, an increase in healthcare spending, and the projected expansion of distribution networks by key industry players.

Have Any Query? Ask Our Expert @ https://www.alliedmarketresearch.com/purchase-enquiry/26467

Key Connected Drug Delivery Devices Market Players

• Adherium
• West Pharmaceutical Services, Inc.
• Proteus Digital Health
• AptarGroup Inc.
• Cohero Health, Inc.
• Ypsomed AG
• F. Hoffmann-La Roche Ltd
• BD
• Syncro Technology Corp.
• PROPELLER HEALTH

𝐕𝐀𝐋𝐔𝐄 𝐏𝐑𝐎𝐏𝐎𝐒𝐈𝐓𝐈𝐎𝐍𝐒 𝐑𝐄𝐋𝐀𝐓𝐄𝐃 𝐓𝐎 𝐓𝐇𝐄 𝐑𝐄𝐏𝐎𝐑𝐓:

• Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
• Comprehensive quantitative and qualitative insights at segment and sub-segment level
• Covid 19 impact trends and perspective
• Granular insights at global/regional/country level
• Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
• Blanket coverage on competitive landscape
• Winning imperatives
• Exhaustive coverage on ‘Strategic Developments’ registered by leading players of the market.

 

Other Trending Reports in Life Science Domain-

Skin Cancer Treatment Market https://www.alliedmarketresearch.com/skin-cancer-treatment-market-A17526

Sharps Containers Market https://www.alliedmarketresearch.com/sharps-containers-market-A17525

Pruritus Therapeutics Market https://www.alliedmarketresearch.com/pruritus-therapeutics-market-A17521

 

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

 

Contact:

David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com